Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis in vivo model and influenced the neuropathological pattern of ME-49 strain
Sign Up to like & getrecommendations! Published in 2019 at "Parasitology"
DOI: 10.1017/s0031182019001604
Abstract: Abstract This study evaluated the effects of rosuvastatin in vivo on toxoplasmosis chronic infection. Thirty-five Swiss mice were orally infected (ME-49 strain). After 50 days, the mice were separated into five groups: GI – non-infected,… read more here.
Keywords: toxoplasmosis; strain; rosuvastatin; chronic toxoplasmosis ... See more keywords